2021年2期
刊物介紹
Cancer Biology & Medicine is a peer-reviewed open-access journal of Chinese Anti-cancer Association (CACA), which is the leading professional society of oncology in China. The journal quarterly provides innovative and significant information on biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China. The scope covers the following topics: ● Cancer epigenetics ● Cancer stem cell ● Improved in vivo and in vitro cancer models ● Cancer prevention and epidemiology ● Biomarkers for predicting drug response ● Mechanism of drug sensitivity and resistance ● New approaches for cancer detection and diagnosis ● Oncology clinical trials ● Targeted therapy ● Multidisciplinary treatment for cancer Author benefits: ● Easy online submission via Editorial Manager ● Efficient and professional peer-review by expert referees from around the world ● Rapid pre-print online publication ● No charge for publication and Open Access ● International visibility - the journal is available free online
Cancer Biology & Medicine
- Stimuli-responsive nanocarriers for therapeutic applications in cancer
- Recent progress of nanotechnology-based theranostic systems in cancer treatments
- Nanomaterial-based delivery vehicles for therapeutic cancer vaccine development
- Gold-based nanomaterials for the treatment of brain cancer
- Nanotechnology assisted photo- and sonodynamic therapy for overcoming drug resistance
- The biological role of the CXCL12/CXCR4 axis in esophageal squamous cell carcinoma
- Epithelial-mesenchymal transition-related circular RNAs in lung carcinoma
- Circular RNAs: new biomarkers of chemoresistance in cancer
- Biological roles and potential clinical values of circular RNAs in gastrointestinal malignancies
- Biomaterial-based platforms for cancer stem cell enrichment and study
- BRCA mutation rate and characteristics of prostate tumor in breast and ovarian cancer families: analysis of 6,591 Italian pedigrees
- sLex expression in invasive micropapillary breast carcinoma is associated with poor prognosis and can be combined with MUC1/EMA as a supplementary diagnostic indicator
- Targeting FGFR in non-small cell lung cancer: implications from the landscape of clinically actionable aberrations of FGFR kinases
- Three-dimensional collagen-based scaffold model to study the microenvironment and drug-resistance mechanisms of oropharyngeal squamous cell carcinomas
- A nomogram-based immune-serum scoring system predicts overall survival in patients with lung adenocarcinoma
- Analysis of the HNF4A isoform-regulated transcriptome identifies CCL15 as a downstream target in gastric carcinogenesis
- L1CAM overexpression promotes tumor progression through recruitment of regulatory T cells in esophageal carcinoma
- The relationship between treatment-induced hypertension and efficacy of anlotinib in recurrent or metastatic esophageal squamous cell carcinoma
- CD13 inhibition augments DR4-induced tumor cell death in a p-ERK1/2-independent manner
- LncRNA HIF1A-AS2 accelerates malignant phenotypes of renal carcinoma by modulating miR-30a-5p/SOX4 axis as a ceRNA
- A novel expressed prostatic secretion (EPS)-urine metabolomic signature for the diagnosis of clinically significant prostate cancer
- Hypoxic microenvironment induced spatial transcriptome changes in pancreatic cancer